Skip to main content
Log in

Sequential FDG-PET/CT after Neoadjuvant Chemotherapy is a Predictor of Histopathologic Response in Patients with Head and Neck Squamous Cell Carcinoma

  • Research Article
  • Published:
Molecular Imaging and Biology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate whether 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography (FDG-PET/CT) more accurately predicts the histopathologic response to neoadjuvant chemotherapy (NAC) than magnetic resonance imaging (MRI) in patients with head and neck squamous cell carcinoma (HNSCC).

Procedures

Sixteen patients with HNSCC underwent FDG-PET/CT and MRI scans before and after one cycle of NAC, followed by surgical resection. The 26 surgically resected specimens of the 16 patients were analyzed. Decreases in maximum standardized uptake value (SUVmax) or in tumor maximum size (diametermax) were calculated, and their accuracies for the prediction of histopathologic response were evaluated.

Results

In histopathologic responders (n = 7), percent decreases in SUVmax were significantly higher (P < 0.001) than in non-responders (n = 19). Applying a cut-off point of 55.5%, the histopathologic response could be predicted with a sensitivity and specificity of 86% and 95%, respectively.

Conclusion

FDG-PET/CT can predict histopathologic NAC responses with higher accuracy than MRI in HNSCC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Pignon JP, Bourhis J, Domenge C et al (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355:949–955

    PubMed  CAS  Google Scholar 

  2. Pignon JP, le Maître A, Maillard E et al (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17, 346 patients. Radiother Oncol 92:4–14

    Article  PubMed  Google Scholar 

  3. The Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1324:1685–1690

    Google Scholar 

  4. Lefebvre JL, Chevalier D, Luboinski B et al (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890–899

    Article  PubMed  CAS  Google Scholar 

  5. Ensley JF, Jacobs JR, Weaver A et al (1984) Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 54:811–814

    Article  PubMed  CAS  Google Scholar 

  6. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216

    Article  PubMed  CAS  Google Scholar 

  7. Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247

    Article  PubMed  CAS  Google Scholar 

  8. Veit-Haibach P, Luczak C, Wanke I et al (2007) TNM staging with FDG-PET/CT in patients with primary head and neck cancer. Eur J Nucl Med Mol Imaging 34:1953–1962

    Article  PubMed  Google Scholar 

  9. Nishiyama Y, Yamamoto Y, Yokoe K et al (2005) FDG PET as a procedure for detecting simultaneous tumours in head and neck cancer patients. Nucl Med Commun 26:239–244

    Article  PubMed  Google Scholar 

  10. Wartski M, Le Stanc E, Gontier E et al (2007) In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT. Nucl Med Commun 28:365–371

    Article  PubMed  Google Scholar 

  11. Dalsaso TA, Lowe VJ, Dunphy FR et al (2007) FDG-PET and CT in evaluation of chemotherapy in advanced head and neck cancer. Clin Positron Imaging 3:1–5

    Article  Google Scholar 

  12. Andrade RS, Heron DE, Degirmenci B et al (2006) Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys 65:1315–1322

    Article  PubMed  Google Scholar 

  13. Weber WA, Ott K, Becker K et al (2001) Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 19:3058–3065

    PubMed  CAS  Google Scholar 

  14. Ott K, Fink U, Becker K et al (2003) Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol 15:4604–4610

    Article  Google Scholar 

  15. Benz MR, Czernin J, Allen-Auerbach MS et al (2009) FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas. Clin Cancer Res 15:2856–2863

    Article  PubMed  CAS  Google Scholar 

  16. Kodaira T, Fuwa N, Tachibana H et al (2006) Phase study of S-1 and nedaplatin for patients with recurrence of head and neck cancer. Anticancer Res 26:2265–2268

    PubMed  CAS  Google Scholar 

  17. Becker K, Mueller JD, Schulmacher C et al (2003) Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 98:1521–1530

    Article  PubMed  Google Scholar 

  18. Metz CE (1989) Some practical issues of experimental design and data analysis in radiological ROC studies. Invest Radiol 24:234–245

    Article  PubMed  CAS  Google Scholar 

  19. Cognetti F, Pinnarò P, Carlini P et al (1988) Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer. Cancer 62:251–261

    Article  PubMed  CAS  Google Scholar 

  20. Cognetti F, Pinnarö P, Ruggeri EM et al (1989) Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer. J Clin Oncol 7:829–837

    PubMed  CAS  Google Scholar 

  21. Al-Kourainy K, Kish J, Ensley J et al (1987) Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancer. Cancer 59:233–238

    Article  PubMed  CAS  Google Scholar 

  22. Jacobs C, Goffinet DR, Goffinet L et al (1987) Chemotherapy as a substitute for surgery in the treatment advanced resectable head and neck cancer. A report from the Northern California Oncology Group. Cancer 60:1178–1183

    Article  PubMed  CAS  Google Scholar 

  23. Brun E, Kjellén E, Tennvall J et al (2002) FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 24:127–135

    Article  PubMed  Google Scholar 

  24. Clark JR, Fallon BG, Dreyfuss AI et al (1988) Chemotherapeutic strategies in the multidisciplinary treatment of head and neck cancer. Semin Oncol 15:35–44

    PubMed  CAS  Google Scholar 

  25. Yamane T, Daimaru O, Ito S et al (2004) Decreased 18F-FDG uptake 1 day after initiation of chemotherapy for malignant lymphomas. J Nucl Med 45:1838–1842

    PubMed  Google Scholar 

  26. Bjurberg M, Henriksson E, Brun E et al (2009) Early changes in 2-deoxy-2-[18F]fluoro-D-glucose metabolism in squamous-cell carcinoma during chemotherapy in vivo and in vitro. Cancer Biother Radiopharm 24:327–332

    Article  PubMed  CAS  Google Scholar 

  27. Weber WA, Wieder H (2006) Monitoring chemotherapy and radiotherapy of solid tumors. Eur J Nucl Med Mol Imaging 33:27–37

    Article  PubMed  Google Scholar 

  28. Srinivas SM, Dhurairaj T, Basu S et al (2009) A recovery coefficient method for partial volume correction of PET images. Ann Nucl Med 23:341–348

    Article  PubMed  Google Scholar 

  29. Hawkins DS, Schuetze SM, Butrynski JE et al (2005) [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. J Clin Oncol 23:8828–8834

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was financially supported by Kasahara Fund for the promotion of cancer research.

Conflict of Interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masahiro Kikuchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kikuchi, M., Shinohara, S., Nakamoto, Y. et al. Sequential FDG-PET/CT after Neoadjuvant Chemotherapy is a Predictor of Histopathologic Response in Patients with Head and Neck Squamous Cell Carcinoma. Mol Imaging Biol 13, 368–377 (2011). https://doi.org/10.1007/s11307-010-0364-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11307-010-0364-3

Key words

Navigation